Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bilcare Global Clinical Supplies, a single-source provider of clinical trial supplies and services, has enhanced its ability to develop functionally viable and innovative formulation dosage forms for preclinical and early-phase drugs.
Subscribe to our email newsletter
According to Vincent Santa Maria, president of Bilcare Global Clinical Supplies, Americas, the addition of new technology – which includes fluid bed granulation and enhanced capsule-filling equipment – is part of the company’s capital investment program in its US facilities.
The fluid bed granulation technology extends Bilcare’s solid-dosage formulation capabilities. Equipped with Wurster coating inserts, the system enables Bilcare to deliver specialized, high-precision coating processes for granules and non-pareils for the creation of top-quality sustained- and controlled-release tablet and capsule formulations.
Frank Santillo, senior director of research services at Bilcare, said: “Bilcare’s R&D center can now develop a broad array of dosage forms with innovative delivery mechanisms that exceed those developed by pharmaceutical companies. Most importantly, we now have the expertise to take a drug candidate from concept to clinical production without the client suffering critical and costly delays as a result of hand-offs.”